Cargando…

Added survival benefit of whole brain radiotherapy in brain metastatic non-small cell lung cancer: Development and external validation of an individual prediction model

BACKGROUND: The heterogeneous survival benefit of whole brain radiotherapy (WBRT) in brain metastatic non-small cell lung cancer (NSCLC) was prospectively evidenced in the Quality of Life after Treatment for Brain Metastases (QUARTZ) trial, resulting in inconsistent guideline recommendations and div...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trikhirhisthit, Kyrhatii, Setakornnukul, Jiraporn, Thephamongkhol, Kullathorn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796174/ https://www.ncbi.nlm.nih.gov/pubmed/36591469 http://dx.doi.org/10.3389/fonc.2022.911835

Ejemplares similares

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
por: Setakornnukul, Jiraporn, et al.
Publicado: (2018)

Cutoff point of neutrophil-to-lymphocyte ratio for predicting survival in nasopharyngeal carcinoma
por: Setakornnukul, Jiraporn, et al.
Publicado: (2021)

Outcomes of Patients With Breast Cancer Treated With or Without Internal Mammary Irradiation: A Single-Center, Retrospective Propensity Score–Matched Study
por: Jitwatcharakomol, Tanun, et al.
Publicado: (2022)

RONC-09. The comparison of dosimetric parameters for predicting radiation-induced cataract in pediatric patients
por: Leangcharoensap, Siriphan, et al.
Publicado: (2022)

Preoperative admission is non-essential in most patients receiving elective laparoscopic cholecystectomy: A cohort study
por: Tunruttanakul, Suppadech, et al.
Publicado: (2023)

MBCL-10. LOCAL RECURRENCE AND SURVIVAL OUTCOMES OF MEDULLOBLASTOMA (MB) IN ADOLESCENT AND YOUNG ADULT PATIENTS (AYA)
por: Rongthong, Warissara, et al.
Publicado: (2020)

Survival Benefits of Anti-PD-1 Therapy in Combination With Radiotherapy in Chinese Melanoma Patients With Brain Metastasis
por: Wu, Shuang, et al.
Publicado: (2021)

Intraoperative Radiotherapy in Brain Malignancies: Indications and Outcomes in Primary and Metastatic Brain Tumors
por: Cifarelli, Christopher P., et al.
Publicado: (2021)

Whole brain radiotherapy for brain metastasis
por: McTyre, Emory, et al.
Publicado: (2013)

Computer Tomography Radiomics-Based Nomogram in the Survival Prediction for Brain Metastases From Non-Small Cell Lung Cancer Underwent Whole Brain Radiotherapy
por: Zhang, Ji, et al.
Publicado: (2021)

Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer
por: Zheng, Yajuan, et al.
Publicado: (2020)

Individualized Prediction of Survival Benefits of Pancreatectomy Plus Chemotherapy in Patients With Simultaneous Metastatic Pancreatic Cancer
por: Nie, Duorui, et al.
Publicado: (2021)

Optimizing Whole Brain Radiotherapy Treatment and Dose for Patients With Brain Metastases From Small Cell Lung Cancer
por: Li, Hanming, et al.
Publicado: (2021)

Whole Brain Radiation Therapy Plus Focal Radiation Boost May Generate Better Survival Benefit for Brain Metastases From Non-small Cell Lung Cancer
por: Ni, Meng, et al.
Publicado: (2020)

Treatment of brain metastases from gastrointestinal primaries: Comparing whole-brain radiotherapy and stereotactic radiosurgery in terms of survival
por: Dincer, Selvi, et al.
Publicado: (2021)

Radiotherapy concurrently with weekly cisplatin, followed by adjuvant chemotherapy, for N2–3 nasopharyngeal cancer: a multicenter trial of the Forum for Nuclear Cooperation in Asia
por: Ohno, Tatsuya, et al.
Publicado: (2013)

Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection—Outcome, Prognostic Factors, and Recurrence Patterns
por: El Shafie, Rami A., et al.
Publicado: (2020)

Corrigendum: Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer
por: Zheng, Yajuan, et al.
Publicado: (2020)

Automated field‐in‐field whole brain radiotherapy planning
por: Huang, Kai, et al.
Publicado: (2022)

Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity
por: Fritz, Corinna, et al.
Publicado: (2018)

Development and validation of a prognostic prediction model including the minor lymphatic pathway for distant metastases in cervical cancer patients
por: Thephamongkhol, Kullathorn, et al.
Publicado: (2022)

Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
por: Jiang, Cecilia, et al.
Publicado: (2021)

Reirradiation of Whole Brain for Recurrent Brain Metastases: A Case Report of Lung Cancer With 12-Year Survival
por: Li, Minmin, et al.
Publicado: (2021)

Hippocampal‐sparing whole‐brain radiotherapy using the Elekta equipment
por: Nevelsky, Alexander, et al.
Publicado: (2013)

Clinical implementation of automated treatment planning for whole‐brain radiotherapy
por: Han, Eun Young, et al.
Publicado: (2021)

Long-term survival with a combination of immunotherapy, anti-angiogenesis, and traditional radiotherapy in brain metastatic small cell lung cancer: a case report
por: Long, Yan-yan, et al.
Publicado: (2023)

Evaluating Magnetic Resonance Spectroscopy as a Tool for Monitoring Therapeutic Response of Whole Brain Radiotherapy in a Mouse Model for Breast-to-Brain Metastasis
por: Chae, Woon Hyung, et al.
Publicado: (2019)

A simplified non-coplanar volumetric modulated arc therapy for the whole brain radiotherapy with hippocampus avoidance
por: Xue, Juan, et al.
Publicado: (2023)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
por: Guo, Yadong, et al.
Publicado: (2019)

Prospective memory impairment following whole brain radiotherapy in patients with metastatic brain cancer
por: Cheng, Huaidong, et al.
Publicado: (2018)

Radiation Necrosis – A Growing Problem in a Case of Brain Metastases Following Whole Brain Radiotherapy and Stereotactic Radiosurgery
por: Song, Yee Pei, et al.
Publicado: (2018)

Predictors for Long-Term Survival Free from Whole Brain Radiation Therapy in Patients Treated with Radiosurgery for Limited Brain Metastases
por: Gorovets, Daniel, et al.
Publicado: (2015)

The Cognitive Effects of Radiotherapy for Brain Metastases
por: Lehrer, Eric J., et al.
Publicado: (2022)

Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
por: Nieder, Carsten, et al.
Publicado: (2023)

Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of Brain Metastases Leading to Improved Survival in Patients With Favorable Prognostic Factors
por: Khan, Muhammad, et al.
Publicado: (2019)

Choice of radiotherapy modality for the combined treatment of non-small cell lung cancer with brain metastases: whole-brain radiation therapy with simultaneous integrated boost or stereotactic radiosurgery
por: Dong, Xiaotao, et al.
Publicado: (2023)

Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment
por: Kong, Cheng, et al.
Publicado: (2023)

Could patients benefit from whole-brain radiotherapy with unilateral hippocampus sparing?
por: Sapienza, Lucas Gomes, et al.
Publicado: (2021)

MR-Guided Radiotherapy for Brain and Spine Tumors
por: Maziero, Danilo, et al.
Publicado: (2021)

Parotid gland dose reduction in the hippocampus avoidance whole-brain radiotherapy using helical tomotherapy
por: Shimizu, Hidetoshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4nkg071s1uedt9ik1o79chnvga